Welcome to our dedicated page for Kadant SEC filings (Ticker: KAI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Kadant Inc. (NYSE: KAI) SEC filings page provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. Kadant is incorporated in Delaware and lists its common stock on the New York Stock Exchange under the symbol KAI, as noted in its Form 8-K filings. Through these documents, investors can review how the company reports its financial results, describes material events, and manages its capital structure.
Regular current reports on Form 8-K furnish Kadant’s quarterly earnings press releases and investor presentation materials. In these filings, the company discusses revenue, net income, earnings per share, bookings, and cash flow, and presents non-GAAP measures such as organic revenue, adjusted net income, adjusted EPS, EBITDA, adjusted EBITDA, adjusted EBITDA margin, and free cash flow. The filings explain which items are excluded from these non-GAAP metrics and why management uses them to assess underlying performance.
Other 8-K filings document material corporate actions, such as the completion of the acquisition of Clyde Industries Holdings, Inc. and amendments to Kadant’s Amended and Restated Credit Agreement. For example, one filing describes an Eighth Amendment that increased revolving loan commitments, extended the maturity of the unsecured credit facility, adjusted multicurrency and letter of credit sublimits, and added an Australian subsidiary as an authorized borrower. These disclosures help readers understand Kadant’s financing arrangements and acquisition activity.
On Stock Titan, Kadant’s filings are updated as they are made available through the EDGAR system. AI-powered summaries highlight the key points in lengthy documents, helping users quickly identify items related to earnings, credit facilities, acquisitions, and other significant developments. Investors can also use this page to trace the history of Kadant’s reported non-GAAP measures, review the terms of its credit agreements, and follow the regulatory record surrounding its strategic transactions.
Kadant Inc. is asking stockholders to vote at the 2026 annual meeting on electing two directors, approving a non-binding say-on-pay resolution, and ratifying KPMG LLP as independent auditor. The meeting will be held May 20, 2026, both at the Westford, MA office and via live webcast.
The proxy describes a pay-for-performance program using earnings per share growth, return on equity, and adjusted EBITDA to set bonuses and equity awards. It also highlights 2025 results, including $1.05 billion in revenue, adjusted EBITDA of $216 million, and operating cash flow of $171 million, along with detailed governance, board skills, and sustainability practices.
Kadant Inc: The Vanguard Group filed Amendment No. 7 to its Schedule 13G/A reporting that it beneficially owns 0 shares (0%) of Kadant common stock following an internal realignment.
The filing states the realignment occurred on January 12, 2026 and that certain Vanguard subsidiaries will report holdings separately; signature dated March 27, 2026.
Kadant Inc. President & CEO Jeffrey L. Powell reported a bona fide gift of 48,667 shares of Kadant common stock on March 11, 2026. The shares were transferred for no consideration to the Jeffrey L. Powell Revocable Trust, where Powell serves as trustee.
Powell and his immediate family are the sole beneficiaries of the trust, and he remains the beneficial owner of the securities held by it. After the transfer, he directly owned 12,282 shares and indirectly held 48,667 shares through the revocable trust.
ALBERTINE JOHN M reported acquisition or exercise transactions in this Form 4 filing.
Kadant Inc. director John M. Albertine received a grant of 513 Restricted Stock Units on common stock. Each RSU represents the right to receive one share of Kadant common stock and was granted at a price of $0.00 per unit as compensation, not an open-market purchase.
The RSUs vest in equal installments on the last day of each quarter of Kadant’s fiscal 2026, as long as Albertine continues to serve as a director. Following these transactions, he holds 7,834 shares of Kadant common stock directly, plus the 513 RSUs scheduled to vest over 2026.
Kadant Inc. director Thomas C. Leonard reported receiving a grant of 513 Restricted Stock Units on March 11, 2026. Each RSU represents one share of Kadant common stock and will vest in equal installments on the last day of each fiscal 2026 quarter, as long as he continues to serve as a director.
Following this award, Leonard holds 4,513 shares of Kadant common stock directly, and 513 RSUs that are scheduled to convert into additional shares as they vest.
Painter Jonathan W reported acquisition or exercise transactions in this Form 4 filing.
KADANT INC director Jonathan W. Painter received a grant of 513 Restricted Stock Units (RSUs) on common stock. Each RSU represents one share of Kadant common stock and vests in equal installments on the last day of each fiscal 2026 quarter, as long as he continues serving as a director. After this award, he directly holds 513 RSUs and 8,748 common shares, plus 3 additional common shares held indirectly by his son.
O'Mara Rebecca Martinez reported acquisition or exercise transactions in this Form 4 filing.
Kadant Inc. director Rebecca Martinez O'Mara received a grant of 513 Restricted Stock Units. Each RSU represents the right to receive one share of Kadant common stock, vesting in equal installments on the last day of each Kadant fiscal quarter in 2026, as long as she continues serving as a director.
Following this grant, she directly holds 1,272 shares of Kadant common stock, in addition to the new RSU award. This filing reflects a routine, stock-based compensation grant rather than an open-market purchase or sale.
Russell Erin L reported acquisition or exercise transactions in this Form 4 filing.
Kadant Inc. director Erin L. Russell received an equity grant of 513 Restricted Stock Units on common stock as compensation. Each RSU represents one share of Kadant common stock and will vest in equal installments on the last day of each quarter of fiscal 2026, as long as she continues serving as a director.
Following the transactions reported, she directly holds 3,197 shares of Kadant common stock, in addition to the 513 RSUs awarded.
Kadant Inc Senior Vice President Michael C. Colwell reported multiple compensation-related stock transactions tied to restricted stock units (RSUs). On March 10, 2026, he exercised RSUs to acquire 1,632 shares of common stock at a conversion price of $0.00 per share.
To cover tax obligations, 743 shares of common stock were disposed of at $334.17 per share through issuer tax withholding, not open-market sales. After these vesting and tax-withholding entries, Colwell directly holds 3,945 shares of Kadant common stock. Footnotes state these are one-third vesting installments from performance- and time-based RSU awards granted in 2023, 2024, and 2025, each converting to common stock on a one-for-one basis.